Experimental and Molecular Medicine
Impact Factor Trend (2018–2026)
Clarivate IF trend for Experimental and Molecular Medicine
SCImago Journal Rank citation prestige weighting
154 papers with at least that number of citations each
Aims & Scope
Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: Cancer biology Immunology Neuroscience Cardiovascular biology Genetics and genomics Gene therapy Metabolic diseases Stem cells and regenerative medicine Physiology and diseases Molecular Medicine.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
BIOCHEMISTRY & MOLECULAR BIOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL
BIOCHEMISTRY & MOLECULAR BIOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisExperimental and Molecular Medicine (acronym: emm, abbr: EXP MOL MED, ISSN: 1226-3613) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in South Korea since 1999. The periodical holds a Journal Impact Factor (JIF) of 17.5, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 5.123 (Q1), an H-index of 154.
The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 162 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,251 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics